Design Therapeutics, Inc. (DSGN) Tops Q2 EPS by 2c

Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q2 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.

You May Also Be Interested In

• Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
• Alabama Power Co. 5.875% Sr. Notes Series 2007b (ALM) Tops Q2 EPS by 62c
• Black Rock Coffee Bar, Inc. (BRCB) Misses Q2 EPS by 1c